Abstract: The present invention relates to a method for screening drugs for use in treating hypertension using the tubular renin-angiotensinogen system identified by the present invention. The invention further relates to a method to diagnose sodium status and sensitivity in an individual by measuring urinary angiotensinogen or angiotensin-I.
Type:
Application
Filed:
October 16, 2002
Publication date:
February 20, 2003
Applicant:
University of Utah Research Foundation, a Utah corporation
Inventors:
Andreas Rohrwasser, Terry Morgan, Jean-Marc Lalouel